{"name":"Nihon Medi-Physics Co., Ltd.","slug":"nihon-medi-physics-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNVzVzY2lOdXF5LUdobWMya2M5bHlpZ0ZWUWRDb3dWR085OWk5MHlRQ25nbzFxcXBrOTlseFB0amJsNEFVemtQVGplblJyLTFzcWNIV1oxUFIwSjZyekRzYno3YTI0N1Nfckl1NzNtNXduYlJvVTcyUWhyS0RGYWp0aVA3ZnVFcGVjdXphYXp5RTFMdWxocjNldUdtTHF0UHNOS0MyaG5Pb1Yxd2VhTnh4M3MtTWRMZzFVb0RoYk9xVjhBZjI0ck1hclo2QWFVYXhwak91NnY1WWhILUdjNVJqYzBqdTI4RDlMd3pfbEdMWGFsSi1zUUdBRldVdjVHbW5uSFpOdklFbnJVNXBQeWhhSHhVTGtubzBwV0tYRkhJa3BmaDg5X1Bwb0tkVmY?oc=5","date":"2026-04-07","type":"pipeline","source":"Cureus","summary":"Evaluating the Impact of Sex-Specific Artificial Intelligence on Bone Metastasis Detection: VSBONE Bone Scan Index (BSI) Version 2.1 Versus Version 3.0 - Cureus","headline":"Evaluating the Impact of Sex-Specific Artificial Intelligence on Bone Metastasis Detection: VSBONE Bone Scan Index (BSI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOak9VbDJNQzV0NGx0ek9qU2ROcFVFRFVHbFNkbF9FSlR3eGY0Zl91U2lfWWRVME13RkxZLWRWR2JPV2ZfTE9fenpzYThzNzJmYmU1S3U2R2N1YXo1cnRuQjdvcW5hLWFneC1pbXJ6Wi1nSTdkRjktTTJOdnlVYkRYc09kamh4QXRXeHVySVJoQTdLUzJTNG9zWnEwMA?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Market Driver Insights: The Impact of Recent Advancements on the Nuclear Medicine Diagnostics Market - openPR.com","headline":"Market Driver Insights: The Impact of Recent Advancements on the Nuclear Medicine Diagnostics Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNaVlENU92REJRbjQyZU5XQ3U1NnBabzdZVUpQT1BLVHBvV2diRDdrQXpSQ1JlMDQwY2NzRlJELTlxQzUwQkNwV3l2V2xVZFQxVmRjTGhFZmRia2ZsRlY3YzAzZjJwZ1gzX2FkSUF5bWtXS3dwSWtGMVNvQXFCVzdDNTU2RW9yTGVJb0R0cFhhcHZLQjR0djQzWGdETnZmczc2VGJMVnhfeWxlM19HR0tja21PM2lwQ0RyaHdMYzdhUDM2bHl0ZFJ0QjZzYmEtcTFSNTQ0ZDhqZGFuMVFaR19SSGFyWXZqbWtoMzZjcGxBVQ?oc=5","date":"2026-02-12","type":"pipeline","source":"PR Newswire","summary":"Radiopharmaceuticals Market to Reach $21.8 Billion by 2033 Globally, at 10.6% CAGR: Allied Market Research - PR Newswire","headline":"Radiopharmaceuticals Market to Reach $21.8 Billion by 2033 Globally, at 10.6% CAGR: Allied Market Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFByZGhHdnRKdWp0OWl2MjNZOHhtVF85XzRJOFpoRUpnYnBXRDhKRk5qREZCam1QeEJmLXNjUzd6SmpXNl9pd294NHVVMFhjR2RfU2dvTVJVbU9DVjJhOGFMc3ByNnBoSm84S2RSX3BJOGtjNWlxMTRTU2Zn?oc=5","date":"2025-12-20","type":"trial","source":"Wiley","summary":"Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials - Wiley","headline":"Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE43LV9TTVNiNERabWFPUmJEajAzMUxMTFp4aWs0eTg3YzJXelB0bTBDNkNjclBQdUpCR2ZYMmhlQzNmel90QlplX3ptUmpHOFh0QzN5cXc4ejVKRmdyZmdV?oc=5","date":"2025-12-01","type":"trial","source":"Nature","summary":"Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease - Nature","headline":"Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNbjJSZEp5d0VfMTNjUVZSclJaLWg2TU9vWUhhVDBZaG83cC11bFpYbjlyMFJGSi1vVW5TOWY1TldUU1pwMHQzUUU5N0RoSktOblZsak1xZHJxbHVSZWc5anNmSEJPdEViM3FIcUZnVkhNWE9TcmhLVUl6TlhZRnlFbjliOXpzdlc1ZVpwTXJpZ3lRTUhlN2JGUU9JbWVVdDd2a3VlNXNMNzBMdEEtNmVweVZsc0hGcUdtdHc?oc=5","date":"2025-08-02","type":"pipeline","source":"BioSpectrum Asia","summary":"APAC building on enough supply network for radiopharmaceuticals - BioSpectrum Asia","headline":"APAC building on enough supply network for radiopharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOSldmV1dEVEU5Z2Y0alo1bUZqby12SURWRTNON0NMRFhMRkdFY25KdDRaRDhHUkNvQmZ6NTBlOGlYaXRoeWVlZVZvblctVVZ4ZUE0NEFTejZzeDc3NnF2dEpHOHp5ek85cU1RVlViOVlGbnB6ZTVnVXNaTWdPSXQ4aU1GUWZQRlVoQjBmMkpBdFBGeUFvdG14U0ZhMFZGQnVReThmSml3TQ?oc=5","date":"2025-04-02","type":"deal","source":"BioWorld News","summary":"GE Healthcare taps into Japan radiopharma market with Nihon buy - BioWorld News","headline":"GE Healthcare taps into Japan radiopharma market with Nihon buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNc3E5SE51Z1pnbnpsQU4tMFpKbXJpM2NnWGYxSWRzdkpVNlJQdmtXNmtuc2dueHNCcHdLcmtSLU5PbWxReDFUak1Va0ZlbnVLWmItODdtRDhkSy1iR3hTcFNjZW5VYlBFZ24yYWE0U3NxNWsyWlJFc1RZQlVVUEpKWlY1SFZmXy1OcXRqSFhXR3FKdzBQaWFFamhCcFBTZWx2RkdkVFZoX055Z01CYndkVzh6NGp5R3hIV3l3MmlGUlNZLVBFS3dkTjlYbUVQZzk2V0cybFgtcUVnaDNwaUlwQjQ3aWljbktYLXp6QlItOGNXU0dJVTNrbQ?oc=5","date":"2025-03-31","type":"pipeline","source":"Business Wire","summary":"GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan - Business Wire","headline":"GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxObk1yWFpRRjBnMTY2aFN6Y0VNSFR1VHZFOERrUkJmbjdUU2FFZHRwX0FjMGVGVUNvc2JIeHVmRTcyZUNGaDFHRkdMSmtwWFRkaGU2MmdGaWE4cG5GZldzTFBPYTZ1VjViR2ZTZWhlcTJfM3FRR3ByV0JoRUdsM1JNcFhvVmJKN0RvZ0luSjQ3Q0ROMWhEN2c?oc=5","date":"2024-12-05","type":"regulatory","source":"Imaging Technology News","summary":"GE HealthCare Acquires Remaining Stake in Nihon Medi-Physics - Imaging Technology News","headline":"GE HealthCare Acquires Remaining Stake in Nihon Medi-Physics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOMmlvQ2pIVTZNa2F4NUsyZ2d5MU5GeFpsSFl2cGhJcnE2VjVmMXE1aW1XXzh3U2RqMnljY29qYkZCNy0zY1ZxRjFocmJ1NEhxVTJvMGMxR3ViYVdsWUtSWlZDVXlsY2ZEOTJlV2lXbDV0Z1VZcXUwM1lQUWt1ZUJncWd1ajJ5a2lpdWprWEZrdUVDNndCbG95cl9mQ3BOUzZMV2F2a2ViM3JqN2d4QmJ4TkdVX2NwQzh5RHNhc2VFOHJTUGdCQ0ZYUDBjZUJZdU16N01SNXd6VDE4NGdRVkxpQTJ1dUtHb2ozNXZUSl80aVM3Y21MRFoxZm5hdmNjN25TQUhibDVqcWtyZUZPVWRYUXJHdWhVaFh5SEoxUUVxbWY5UQ?oc=5","date":"2024-12-01","type":"regulatory","source":"Business Wire","summary":"GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical - Business Wire","headline":"GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQb25oNGc1MGtVY09wWEdPTjVFdjlvMlhDLWFhdG5YUnR0NlJMaU0zWnVYR1E4bDVrb1kta3FjRkRxbVNMMVBjWkFWbDBEY0JKVEVYYWZYRU1tZUZLTWlhVm94R0lQMm1IRlduWkpIa2stZ3ZrRE5lZ3YtV1RHRjZ2QnRxLTFLYjk0MFFwamVSOHl2OWMtUnMzRQ?oc=5","date":"2024-10-04","type":"pipeline","source":"Yahoo Finance","summary":"Radiopharmaceuticals Market Size Projected to Soar to USD 16.6 Billion by 2032 with 10.4% CAGR – SNS Insider - Yahoo Finance","headline":"Radiopharmaceuticals Market Size Projected to Soar to USD 16.6 Billion by 2032 with 10.4% CAGR – SNS Insider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQazRmbDdhNF9ld1ZMWk5tV0M4b21ONFktd04zeUp4eVpnMjRRNzUxTXVVR0RlUkVoaWxIOVNwaGZvOTBHVFhDeWNBNzNCQzdaZDJMV3MxRWZVREtMUHA4X04tUjRsUjRsa2Z1VlA1MmpYVmpiajNLSzViMzNJQzFGZlJaRFhWbkJCamVVM2JwTnJBeVZZZVBjNndSeDdDcDhUWng4d3pwVkFFb3lVUF95cndKNFA0N25zcnhFbTN5UUlmbDNMRVZKYjFfMnNJeDNOMXB3YnppQXdIcmJPVnlPZ1doOVlpNExaZF9Oa0tsejBUOTBxaUE?oc=5","date":"2018-08-15","type":"pipeline","source":"GlobeNewswire","summary":"Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market - GlobeNewswire","headline":"Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}